Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Some studies have suggested that people who are younger when they enter puberty are more likely to later develop multiple sclerosis (MS). But a new study, published in the online issue of Neurology,...
After following nearly 6,000 patients for more than two decades researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed...
GeNeuro, a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), has announced positive results from the ANGEL-MS study of...
Cleveland Clinic Lou Ruvo Center for Brain Health in the US is now recruiting participants for a new, relapsing remitting multiple sclerosis (RRMS) treatment trial, DELIVER-MS. Cleveland Clinic will...
It was announced yesterday at the Novel Food Commission meeting in Brussels that the European Food Safety Association (EFSA) is reviewing its decision to classify CBD as a novel food. It is thought...
According to a recent study, people with multiple sclerosis (MS), drinking around 290 calories per day of soda or other sugar-sweetened beverages, which is the equivalent to around two cans of non-...
A recent study has revealed that flavonoid-rich cocoa has the potential to improve fatigue in relapsing remitting multiple sclerosis (RRMS) patients. The impact of flavonoids on fatigue had not...
A number of multiple sclerosis (MS) patients are prescribed pregabalin or gabapentin to help manage MS symptoms such as pain and spasticity, but back in October 2018 the government took the decision...
The US Food and Drug Administration (FDA) has released a statement regarding the safety of plasma infusions. It claims it has seen a rise in the number of establishments in the US offering infusions...
In a recent study, researchers have shown that compounds based on chloroindazole reduce inflammation as well as promote neuroprotection and remyelination, improving the primary symptoms in a mouse...

Pages